AKI Risk in COVID-19 vs Flu Not Disproportionately Higher With RAASi Use
New study is the first to examine the effect of the use of renin-angiotensin-aldosterone system inhibitors on AKI in COVID-19.
New study is the first to examine the effect of the use of renin-angiotensin-aldosterone system inhibitors on AKI in COVID-19.
More than 40 percent of fully trained nurses from home care services reported medication errors within a 12-month period.
Modifications to labelling standards for acetaminophen, were not associated with trends in hospital admission for accidental acetaminophen overdose.
Medicare announced Thursday that it will limit its coverage of the pricey new drug Aduhelm to patients with Alzheimer disease enrolled in clinical trials of the drug.
A subgroup analysis of the ASPREE trial could not conclusively demonstrate clear harm or benefit of either cessation or continuation of aspirin.